Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals.
Nat Commun. 2024 Apr 9;15(1):3077. doi: 10.1038/s41467-024-47429-8.
Nat Commun. 2024.
PMID: 38594497
Free PMC article.
Potent induction of humoral and cellular immunity after bivalent BA.4/5 mRNA vaccination in dialysis patients.
Bronder S, Mihm J, Urschel R, Klemis V, Schmidt T, Marx S, Abu-Omar A, Hielscher F, Guckelmus C, Widera M, Sester U, Sester M.
Bronder S, et al. Among authors: guckelmus c.
NPJ Vaccines. 2024 Feb 7;9(1):25. doi: 10.1038/s41541-024-00816-0.
NPJ Vaccines. 2024.
PMID: 38326340
Free PMC article.
Item in Clipboard
NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens.
Hielscher F, Schmidt T, Klemis V, Wilhelm A, Marx S, Abu-Omar A, Ziegler L, Guckelmus C, Urschel R, Sester U, Widera M, Sester M.
Hielscher F, et al. Among authors: guckelmus c.
J Clin Virol. 2022 Dec;157:105321. doi: 10.1016/j.jcv.2022.105321. Epub 2022 Oct 18.
J Clin Virol. 2022.
PMID: 36279695
Free PMC article.
Item in Clipboard
Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens.
Klemis V, Schmidt T, Schub D, Mihm J, Marx S, Abu-Omar A, Ziegler L, Hielscher F, Guckelmus C, Urschel R, Wagenpfeil S, Schneitler S, Becker SL, Gärtner BC, Sester U, Sester M.
Klemis V, et al. Among authors: guckelmus c.
Nat Commun. 2022 Aug 11;13(1):4710. doi: 10.1038/s41467-022-32321-0.
Nat Commun. 2022.
PMID: 35953492
Free PMC article.
Item in Clipboard
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination.
Schmidt T, Klemis V, Schub D, Mihm J, Hielscher F, Marx S, Abu-Omar A, Ziegler L, Guckelmus C, Urschel R, Schneitler S, Becker SL, Gärtner BC, Sester U, Sester M.
Schmidt T, et al. Among authors: guckelmus c.
Nat Med. 2021 Sep;27(9):1530-1535. doi: 10.1038/s41591-021-01464-w. Epub 2021 Jul 26.
Nat Med. 2021.
PMID: 34312554
Free PMC article.
Item in Clipboard
Cite
Cite